The influence of experimental spinal cord injury on carbamazepine pharmacokinetics

Archives of Iranian Medicine

Volumn 9, Issue 3, 2006, Pages 231-235

  Reihani Kermani, Hamed ^a   Ansari, Mehdi ^a   Karamousian, Saeid ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbamazepine; Pharmacokinetics; Spinal cord injury

Indexed keywords

CARBAMAZEPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; EXPERIMENTAL MODEL; GASTROINTESTINAL MOTILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE PERFUSION; LAMINECTOMY; MALE; NERVE LESION; NONHUMAN; RABBIT; SPINAL CORD INJURY; STATISTICAL ANALYSIS; TIME;

ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; ANIMALS; CARBAMAZEPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; MALE; RABBITS; SPINAL CORD INJURIES; THORACIC VERTEBRAE;

EID: 33746442354     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. DeVivo MJ, Black KJ, Stover SL. Causes of death during the first 12 years after spinal cord injury. Arch Phys Med Rehab. 1993; 74: 248-254.
2. Waites KB, Canupp KC, DeVivo MJ. Phagocytosis of urinary pathogens in persons with spinal cord injury. Arch Phys Med Rehab. 1994; 75: 63-66.
3. Jackson AB, Groomes TE. Incidence of respiratory complications following spinal cord injury. Arch Phys Med Rehab. 1994; 75: 270-275.
4. Lopez PG, Urizar JP, Madrazo I. Oral paracetamol bioavailability in rats subjected to experimental spinal cord injury. Biopha Drug Dispo. 1997; 18: 203-211.
5. Segal JL, Brunnemann SR. Clinical pharmacokinetics in patients with spinal cord injuries. Clin Pharmacokinet. 1998; 17: 109-129.
6. Woolsey RM. Chronic pain following spinal cord injury. J Am Paraplegia Soc. 1986; 9: 39-41.
7. Finnerup NB, Gottrup H, Jensen TS. Anticonvulsants in central pain. Expert Opin Pharmacother. 2002; 3: 1411-1420.
8. Halstead LS, Feldman S, Claus-Walker J, Patel VC. Drug absorption in spinal cod injury. Arch Phys Med Rehab. 1985; 66: 289-301.
9. Segal JL, Brunnemann SR, Gordon SK, Eltorai IM. Decreased theophylline bioavailability and impaired gastric emptying in spinal cord injury. Curr Ther Res. 1985; 38: 831-846.
10. Segal JL, Brunnemann SR, Gordon SK, Eltorai IM, Gray DR. Impaired absorption of intramuscularly administered gentamicin in spinal cord injury. Curr Ther Res. 1986; 39: 961-969.
11. Lara GF, Guizar SG, Lopez GP. Effect of experimental spinal cord injury on salicylate bioavailability after oral aspirin administration. Pharmacol Toxicol. 2000; 42: 93-97.
12. Lopez GP, Guizer SG, Castaneda-Hernandez CG. Effects of high and low thoracic spinal cord injury on the oral pharmacokinetics of paracetamol in rats. Pharm Pharmacol Commun. 1999; 5: 579-581.
13. Guizar SG, Grijalva I, Bourland FR, Ceballos SH, Ibarra A, Sahd U. Neuroprotection of completely lacerated spinal cord of adult rats by homotropic and heterotropic transplantation. Rest Neurol Neurosci. 1994; 7: 61-62.
14. Bhatti MM, Hanson GD, Schultz L. Simultaneous determination of phenytoin, carbamazepine, and 10, 11-carbamazepine epoxide in human plasma by high-performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal. 1998; 16: 1233-1240.
15. Sandford PR, Lindblom LB, Haddox JD. Amitriptyline and carbamazepine in the treatment of dysesthetic pain in spinal cord injury. Arch Phys Med Rehab. 1992; 73: 300-301.
16. Gibaldi M. Biopharmaceutics and Clinical Pharmacokinetics. 4th ed. Philadelphia: WB Saunders 1991: 256-302.
17. Fealey RD, Szurszewski JH, Merrit JL, DiMagno EP. Effect of traumatic spinal cord transection on human upper gastrointestinal motility and gastric emptying. Gastroenterology. 1984; 87: 69-75.
18. Guizar SG, Lopez GP, Espitia AL, Mendez S, Hernandez CG, Madrazo I, et al. Histochemical evidence for the increased expression of nicotinamide adenine dinucleotide phosphate-dependent diaphorase in neurons of the myenteric plexus after acute spinal cord injury in adult rat. Neurosci Lett. 1996; 206: 185-188.
19. Krassioukov AV, Weaver LC. Episodic hypertension due to autonomic dysreflexia in acute and chronic spinal cord-injured rat. Am J Physiol. 1995; 268: 2077-2083.
20. Lopez PG, Salas R. Bioavailability of diclofenac after intramuscular administration to rats with experimental spinal cord injury. Pharmacol Toxicol. 1999; 42: 99-101.
21. Ibarra A, Guizar SG, Correa D, Kretschmer R, Grijalava I, Flores MF, et al. Alteration of cyclosporine-A pharmacokinetics after experimental spinal cord injury. J Neurotrauma. 1996; 5: 276-279.
22. Holtz A, Nystron B. Neuropathological changes and neurological function after spinal cord compression in the rat. J Neurotrauma. 1990; 7: 155-167.
23. Das GD. Perspectives in anatomy and pathology of paraplegia in experimental animals. Brain Res Bull. 1989; 22: 7-32.
24. Hall ED, Wolf DL. A pharmacological analysis of the pathophysiological mechanisms of the posttraumatic spinal cord ischemia. J Neurosurg. 1986; 64: 951-961.
25. Guizar SI, Gijalba I, Madrazo I, Bourland FR, Bourland FH, Salgado A, et al. Development of posttraumatic cysts in the spinal cord of rats subjected to severe spinal cord contusion. Surg Neurol. 1994; 41: 241-249.
26. Kerr FWL. Structural and functional evidence of plasticity in the central nervous system. Exp Neurol. 1975; 48: 16-31.
27. Helgren ME, Goldberger ME. The recovery of postural reflexes and locomotion following low thoracic hemisection in adult cats involves compensation by undamaged primary afferent pathways. Exp Neurol. 1993; 123: 17-34.
28. Williams TH, Jew J, Palay SL. Morphological plasticity in the symptomatic chain. Exp Neurol. 1973; 39: 181-203.